MECHANISMS OF ACTIVATION AND SUPPRESSION IN RAT NB-2 LYMPHOMA-CELLS - A MODEL FOR INTERACTIONS BETWEEN PROLACTIN AND THE IMMUNE-SYSTEM

被引:4
作者
BATES, LG [1 ]
GROVE, DS [1 ]
MASTRO, AM [1 ]
机构
[1] PENN STATE UNIV,DEPT MOLEC & CELL BIOL,UNIVERSITY PK,PA 16802
关键词
D O I
10.1006/excr.1995.1192
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Rat Nb 2 lymphoma cells have been widely used to bioassay human growth hormone and many species of prolactin. Because their morphologic characterization suggests a T-cell lineage, Nb 2 cells were examined for their response to the T-cell mitogens concanavalin A, pokeweed mitogen, and phytohemagglutinin P. As expected, a dose-response to rat prolactin was observed; however, attempts to induce proliferation using the conventional T-cell mitogens failed at concentrations normally stimulatory for rat primary lymphocytes. Moreover, when Nb 2 cells were simultaneously incubated with lectin plus a suboptimal concentration of prolactin, a dose-dependent suppression of the stimulatory effects of prolactin was observed with phytohemagglutinin P and pokeweed mitogen, although not with concanavalin A. Culture medium of prolactin-stimulated Nb 2 cells also contained a factor which inhibited normal rat lymphocyte activation by concanavalin A. The factor did not block induction of the IL-2 receptor and proliferation of IL-P-dependent CTLL-2 cells could be restored by exogenous IL-2. Because Nb 2 cells evolved from a lactogen-dependent lymph node tumor, these results may have implications for further understanding the role of pituitary hormones, particularly prolactin, in the immune response to hormone-dependent tumor progression. (C) 1995 Academic Press, Inc.
引用
收藏
页码:567 / 572
页数:6
相关论文
共 21 条
[1]  
BERCZI I, 1981, ACTA ENDOCRINOL-COP, V98, P5506
[2]   SUPPRESSION OF MACROPHAGE ACTIVATION AND LYMPHOCYTE-T FUNCTION IN HYPOPROLACTINEMIC MICE [J].
BERNTON, EW ;
MELTZER, MS ;
HOLADAY, JW .
SCIENCE, 1988, 239 (4838) :401-404
[3]  
COX JH, 1989, IMMUNOLOGY, V66, P83
[4]  
Elias J.J., 1980, Hormonal Proteins and Peptides, V8, P37
[5]   CARBOHYDRATE DIFFERENTIATION ANTIGENS [J].
FEIZI, T .
TRENDS IN BIOCHEMICAL SCIENCES, 1981, 6 (12) :333-335
[6]  
FRIESEN HG, 1982, SERONO S, V49, P101
[7]  
GERTLER A, 1990, RECEPTOR PURIFICATIO, V1, P269
[8]  
GOUT PW, 1980, CANCER RES, V40, P2433
[9]  
GROVE D S, 1991, Endocrine Regulations, V25, P111
[10]   TUMOR-ASSOCIATED CARBOHYDRATE ANTIGENS [J].
HAKOMORI, S .
ANNUAL REVIEW OF IMMUNOLOGY, 1984, 2 :103-126